THE ECONOMIC BURDEN OF POSTOPERATIVE THROMBOEMBOLISM OF PULMONARY ARTERY

Author(s)

Bashlakova E1, Vorobiev P2, Krasnova L2
1The First Moscow State Medical University named after I.M. Sechenov, Moscow, Russia, 2Russian Society for Pharmacoeconomics and Outcomes Research, Moscow, Russia

OBJECTIVES: the costs of treatment of patients with pulmonary embolism (PE), which has developed after large surgery and includes the cost of hospital stay, treatment, the cost of medicines, non-drug technologies and rehabilitation. In most studies, cost estimation is performed using a survey of experts and modeling. The objectives of the study were to conduct a cost analysis of patients with PE, which has showed after the operations in "real" practice. METHODS: A retrospective analysis. When analyzing the costs only direct costs were calculated. Total costs were counted by adding costs of medicines, transaction costs, costs of laboratory and instrumental methods of research, medical services, medical staff, costs of hospital stay. RESULTS:

Conference/Value in Health Info

2014-05, ISPOR 2014, Palais des Congres de Montreal

Value in Health, Vol. 17, No. 3 (May 2014)

Code

PCV50

Topic

Economic Evaluation

Topic Subcategory

Cost/Cost of Illness/Resource Use Studies

Disease

Cardiovascular Disorders

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×